This site uses technical, analytics and third-party cookies.
By continuing to browse, you accept the use of cookies.

Preferences cookies

Ambassador Zappia opens Dompé Foundation and Confindustria workshop in Washington on the challenges of science and technology

S.E. l’Ambasciatrice Zappia e il Dott. Guido Romeo (Dompé farmaceutici)

Washington, DC (June 20, 2023) – The challenges of science are not mere obstacles, but catalysts to push the limits of knowledge, to inspire innovations leading to new, incredible discoveries. These are the words of Italian Ambassador to the United States Mariangela Zappia at the opening of the workshop “Embracing the Challenge in Science: Dompé’s Research from Neurotrophins to AI Driven Drug Discovery” at the Dr. Martin Luther King Jr. Memorial Library of Washington DC.

“Italy and the U.S. share a long tradition of cooperation in the field of science and technology,” said Ambassador Zappia at the event, organized by the Dompé Foundation and Confindustria, on the sidelines of the exhibition “Imagining The Future – Leonardo da Vinci: In The Mind Of An Italian Genius,” the first monographic exhibition dedicated to Leonardo da Vinci’s Codex Atlanticus in the United States, at the MLK Library.

“Investing in our young researchers is investing in the future of science and economic progress,” continued the Ambassador, thanking the Dompé Foundation for having strengthened its offer of fellowships dedicated to Rita Levi Montalcini and stressing that science is no longer confined behind the walls of academia but opens doors to companies and incubators, investing in technology transfer.

At the workshop, closed by Sergio Dompé, President of Dompé Farmaceutici and the Dompé Foundation and moderated by Guido Romeo, Corporate Communication Director of Dompé Farmaceutici, various industry experts spoke, including Gary Pisano, Harry E. Figgie, Professor of Business Administration, Senior Associate Dean of Harvard Business School; Mina Massaro Giordano, Co-Director and Full Professor of Ophthalmology, Penn Dry Eye & Ocular Surface Center at the University of Pennsylvania; Sabra Klein, Professor of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health; Andrew Pekosz, Professor and Co-Director of the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health; Marcello Allegretti, Chief Scientific Officer of Dompé Farmaceutici; Flavio Mantelli, Chief Medical Officer of Dompé Farmaceutici, Head of Neurotrophins R&D.